home > bioproject > PRJEB14674
identifier PRJEB14674
type bioproject
sameAs
organism
title Parkinson’s disease and therapeutic modalities have distinct signatures on the gut microbiome
description Here we present a study of the gut microbiome in relation to PD, which for the first time, includes a systematic stratified analysis to disentangle potential confounding of 41 variables including medications, diet, sex, age, geographic location, body mass index (BMI), constipation, and disease duration. We detected a strong relationship between PD and the microbiome that remained highly significant even after controlling for the confounders. We found significant associations between PD medications and the gut microbiome and were able to detect changes that were unique to medication and distinct from the changes seen in PD. PD samples had significantly elevated abundance of pro-inflammatory taxa from genera Verrucomicrobiaceae Akkermansia and significantly decreased levels of butyrate-producing anti-inflammatory taxa from Lachnospiraceae and Ruminococcaceae families. Butyrate deficiency 7-9 could explain the gastrointestinal problems of PD, including colonic inflammation 4 and leaky gut 5 which may be at the root of the disease.
data type Other
organization
publication
properties 
{...}
dbXrefs
sra-run  ERR1513640ERR1513641ERR1513642ERR1513643ERR1513644ERR1513645ERR1513646ERR1513647ERR1513648ERR1513649 More
sra-submission  ERA670803
biosample  SAMEA4060772SAMEA4060773SAMEA4060774SAMEA4060775SAMEA4060776SAMEA4060777SAMEA4060778SAMEA4060779SAMEA4060780SAMEA4060781 More
sra-study  ERP016332
sra-sample  ERS1231882ERS1231883ERS1231884ERS1231885ERS1231886ERS1231887ERS1231888ERS1231889ERS1231890ERS1231891 More
sra-experiment  ERX1584667ERX1584668ERX1584669ERX1584670ERX1584671ERX1584672ERX1584673ERX1584674ERX1584675ERX1584676 More
distribution JSONJSON-LD
Download
bioproject.xml  HTTPS FTP
status public
visibility unrestricted-access
dateCreated 2017-03-10T00:00:00Z
dateModified 2017-03-10T00:00:00Z
datePublished